PainShield
Commercial- Indications
- Chronic pain, Trigeminal neuralgia, Tendonitis
Company intelligence / Profile preview
NanoVibronix’s products have demonstrated clinical effectiveness in reducing catheter-associated infections, improving quality of life for spinal injury patients, facilitating wound healing, and providing non-pharmacological pain relief. Independent studies presented at major medical conferences support the efficacy of UroShield®, with high patient satisfaction reported. The company continues to expand distribution globally.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NanoVibronix, Inc..